Ever wondered what's really happening behind the scenes in the biotech and pharmaceutical industry? Drug Dealin' pulls back the curtain. Co-hosts Shivu Sharma a...
Kenny and Shivu each cook up three predictions for Biopharma in 2025
NOTE: This episode was recording on January 10th, 2025
Have feedback for us? Leave a comment or email us at [email protected]
--------
57:57
Ep. 1: Do Pharma Companies Avoid Cures?
In this episode, we unpack, examine, and debunk the public perception that drug companies intentionally do not pursue curative therapies, because it is financially less beneficial to them. We speak from our own experience working on curative therapies in Oncology and HCV, discuss how difficult it is to develop cures, the implications of curing a disease for drug companies, and how the industry can do a better job fostering trust with patients.
Have feedback for us? Feel free to leave a comment or send us an email at [email protected]
--------
1:13:48
Ep. 0: Welcome to the Drug Dealin' Podcast!
What is Drug Dealin' going to be about? How are the Drug Dealin' hosts and should you listen to us? What type of content can you expect from this show?
Ever wondered what's really happening behind the scenes in the biotech and pharmaceutical industry? Drug Dealin' pulls back the curtain. Co-hosts Shivu Sharma and Kenny Lalwani, two seasoned BioPharma professionals, offer unparalleled insider insights, dissecting the latest news, trends, and catalysts. Each episode features in-depth discussions and interviews with industry luminaries, giving you honest and unvarnished perspectives you won't find anywhere else.